IRCCS MultiMedica, Via Gaudenzio Fantoli, 16/15, 20138, Milan, Italy.
Cardiovasc Diabetol. 2021 May 7;20(1):101. doi: 10.1186/s12933-021-01289-4.
Several studies suggest that, together with glucose variability, the variability of other risk factors, as blood pressure, plasma lipids, heart rate, body weight, and serum uric acid, might play a role in the development of diabetes complications. Moreover, the variability of each risk factor, when contemporarily present, may have additive effects. However, the question is whether variability is causal or a marker. Evidence shows that the quality of care and the attainment of the target impact on the variability of all risk factors. On the other hand, for some of them causality may be considered. Although specific studies are still lacking, it should be useful checking the variability of a risk factor, together with its magnitude out of the normal range, in clinical practice. This can lead to an improvement of the quality of care, which, in turn, could further hesitate in an improvement of risk factors variability.
几项研究表明,除了血糖变异性,其他风险因素的变异性,如血压、血浆脂质、心率、体重和血清尿酸,可能在糖尿病并发症的发展中起作用。此外,当同时存在多种风险因素时,它们的变异性可能具有累加效应。然而,问题是变异性是因果关系还是一个标志物。有证据表明,护理质量和目标的实现会影响所有风险因素的变异性。另一方面,对于其中一些因素,可以认为存在因果关系。虽然仍缺乏具体研究,但在临床实践中同时检查风险因素的变异性及其超出正常范围的幅度可能会有所帮助。这可以提高护理质量,反过来又可以进一步降低风险因素变异性。